Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients

Cristina Lanni, Giulia Garbin, Antonella Lisa, Fabrizio Biundo, Alberto Ranzenigo, Elena Sinforiani, Giovanni Cuzzoni, Stefano Govoni, Guglielmina Nadia Ranzani, Marco Racchi

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

COMT (Catechol-O methyltransferase) gene is one of the key players in synaptic plasticity and in learning and memory mechanisms. A single nucleotide polymorphism (rs4680; G to A) in the COMT coding region causes Val158Met aminoacid substitution in the corresponding protein, with Val allele exhibiting a 3-to 4-fold increase in enzyme activity compared to Met. With the purpose of examining the influence of COMT as a genetic risk factor for cognitive impairment, we analyzed a sample of 248 healthy subjects, 276 patients affected by Alzheimer's disease (AD), and 70 subjects with mild cognitive impairment (MCI), the latter condition possibly representing a prodrome for dementia. All subjects were analyzed for COMT rs4680 polymorphism and APOE genotype. Our study strengthens data showing that APOE ε4 allele is an independent risk factor for AD and also a risk factor for MCI. Neither COMT alleles nor genotypes proved to be independently associated with the risk of AD or MCI in our sample. However, we found an association between COMT GG genotype (Val/Val) and APOE ε4 carrier status and the risk of AD and MCI. In particular, when GG genotype is included into the multinomial analysis, the risk of AD and MCI due to APOE ε4 allele is increased of about 2-3 fold; moreover, the risk conferred by the combination of G and ε4 alleles is more pronounced in male patients. To our knowledge, this synergistic effect is here shown for the first time on a population sample representative of Caucasian patients.

Original languageEnglish (US)
Pages (from-to)919-926
Number of pages8
JournalJournal of Alzheimer's Disease
Volume32
Issue number4
DOIs
StatePublished - Jan 1 2012
Externally publishedYes

Fingerprint

Catechol O-Methyltransferase
Alzheimer Disease
Alleles
Genotype
Patient Advocacy
Neuronal Plasticity
Single Nucleotide Polymorphism
Dementia
Cognitive Dysfunction
Healthy Volunteers
Learning
Enzymes
Population
Genes
Proteins

Keywords

  • Alzheimer's disease
  • apolipoprotein E
  • catechol-O methyltransferase (COMT)
  • mild cognitive impairment
  • polymorphism
  • risk factor

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients. / Lanni, Cristina; Garbin, Giulia; Lisa, Antonella; Biundo, Fabrizio; Ranzenigo, Alberto; Sinforiani, Elena; Cuzzoni, Giovanni; Govoni, Stefano; Ranzani, Guglielmina Nadia; Racchi, Marco.

In: Journal of Alzheimer's Disease, Vol. 32, No. 4, 01.01.2012, p. 919-926.

Research output: Contribution to journalArticle

Lanni, C, Garbin, G, Lisa, A, Biundo, F, Ranzenigo, A, Sinforiani, E, Cuzzoni, G, Govoni, S, Ranzani, GN & Racchi, M 2012, 'Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients', Journal of Alzheimer's Disease, vol. 32, no. 4, pp. 919-926. https://doi.org/10.3233/JAD-2012-120358
Lanni, Cristina ; Garbin, Giulia ; Lisa, Antonella ; Biundo, Fabrizio ; Ranzenigo, Alberto ; Sinforiani, Elena ; Cuzzoni, Giovanni ; Govoni, Stefano ; Ranzani, Guglielmina Nadia ; Racchi, Marco. / Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients. In: Journal of Alzheimer's Disease. 2012 ; Vol. 32, No. 4. pp. 919-926.
@article{41da3ca4168841538ac2704ad49f2930,
title = "Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients",
abstract = "COMT (Catechol-O methyltransferase) gene is one of the key players in synaptic plasticity and in learning and memory mechanisms. A single nucleotide polymorphism (rs4680; G to A) in the COMT coding region causes Val158Met aminoacid substitution in the corresponding protein, with Val allele exhibiting a 3-to 4-fold increase in enzyme activity compared to Met. With the purpose of examining the influence of COMT as a genetic risk factor for cognitive impairment, we analyzed a sample of 248 healthy subjects, 276 patients affected by Alzheimer's disease (AD), and 70 subjects with mild cognitive impairment (MCI), the latter condition possibly representing a prodrome for dementia. All subjects were analyzed for COMT rs4680 polymorphism and APOE genotype. Our study strengthens data showing that APOE ε4 allele is an independent risk factor for AD and also a risk factor for MCI. Neither COMT alleles nor genotypes proved to be independently associated with the risk of AD or MCI in our sample. However, we found an association between COMT GG genotype (Val/Val) and APOE ε4 carrier status and the risk of AD and MCI. In particular, when GG genotype is included into the multinomial analysis, the risk of AD and MCI due to APOE ε4 allele is increased of about 2-3 fold; moreover, the risk conferred by the combination of G and ε4 alleles is more pronounced in male patients. To our knowledge, this synergistic effect is here shown for the first time on a population sample representative of Caucasian patients.",
keywords = "Alzheimer's disease, apolipoprotein E, catechol-O methyltransferase (COMT), mild cognitive impairment, polymorphism, risk factor",
author = "Cristina Lanni and Giulia Garbin and Antonella Lisa and Fabrizio Biundo and Alberto Ranzenigo and Elena Sinforiani and Giovanni Cuzzoni and Stefano Govoni and Ranzani, {Guglielmina Nadia} and Marco Racchi",
year = "2012",
month = "1",
day = "1",
doi = "10.3233/JAD-2012-120358",
language = "English (US)",
volume = "32",
pages = "919--926",
journal = "Journal of Alzheimer's Disease",
issn = "1387-2877",
publisher = "IOS Press",
number = "4",

}

TY - JOUR

T1 - Influence of COMT Val158Met polymorphism on Alzheimer's disease and mild cognitive impairment in Italian patients

AU - Lanni, Cristina

AU - Garbin, Giulia

AU - Lisa, Antonella

AU - Biundo, Fabrizio

AU - Ranzenigo, Alberto

AU - Sinforiani, Elena

AU - Cuzzoni, Giovanni

AU - Govoni, Stefano

AU - Ranzani, Guglielmina Nadia

AU - Racchi, Marco

PY - 2012/1/1

Y1 - 2012/1/1

N2 - COMT (Catechol-O methyltransferase) gene is one of the key players in synaptic plasticity and in learning and memory mechanisms. A single nucleotide polymorphism (rs4680; G to A) in the COMT coding region causes Val158Met aminoacid substitution in the corresponding protein, with Val allele exhibiting a 3-to 4-fold increase in enzyme activity compared to Met. With the purpose of examining the influence of COMT as a genetic risk factor for cognitive impairment, we analyzed a sample of 248 healthy subjects, 276 patients affected by Alzheimer's disease (AD), and 70 subjects with mild cognitive impairment (MCI), the latter condition possibly representing a prodrome for dementia. All subjects were analyzed for COMT rs4680 polymorphism and APOE genotype. Our study strengthens data showing that APOE ε4 allele is an independent risk factor for AD and also a risk factor for MCI. Neither COMT alleles nor genotypes proved to be independently associated with the risk of AD or MCI in our sample. However, we found an association between COMT GG genotype (Val/Val) and APOE ε4 carrier status and the risk of AD and MCI. In particular, when GG genotype is included into the multinomial analysis, the risk of AD and MCI due to APOE ε4 allele is increased of about 2-3 fold; moreover, the risk conferred by the combination of G and ε4 alleles is more pronounced in male patients. To our knowledge, this synergistic effect is here shown for the first time on a population sample representative of Caucasian patients.

AB - COMT (Catechol-O methyltransferase) gene is one of the key players in synaptic plasticity and in learning and memory mechanisms. A single nucleotide polymorphism (rs4680; G to A) in the COMT coding region causes Val158Met aminoacid substitution in the corresponding protein, with Val allele exhibiting a 3-to 4-fold increase in enzyme activity compared to Met. With the purpose of examining the influence of COMT as a genetic risk factor for cognitive impairment, we analyzed a sample of 248 healthy subjects, 276 patients affected by Alzheimer's disease (AD), and 70 subjects with mild cognitive impairment (MCI), the latter condition possibly representing a prodrome for dementia. All subjects were analyzed for COMT rs4680 polymorphism and APOE genotype. Our study strengthens data showing that APOE ε4 allele is an independent risk factor for AD and also a risk factor for MCI. Neither COMT alleles nor genotypes proved to be independently associated with the risk of AD or MCI in our sample. However, we found an association between COMT GG genotype (Val/Val) and APOE ε4 carrier status and the risk of AD and MCI. In particular, when GG genotype is included into the multinomial analysis, the risk of AD and MCI due to APOE ε4 allele is increased of about 2-3 fold; moreover, the risk conferred by the combination of G and ε4 alleles is more pronounced in male patients. To our knowledge, this synergistic effect is here shown for the first time on a population sample representative of Caucasian patients.

KW - Alzheimer's disease

KW - apolipoprotein E

KW - catechol-O methyltransferase (COMT)

KW - mild cognitive impairment

KW - polymorphism

KW - risk factor

UR - http://www.scopus.com/inward/record.url?scp=84872311976&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872311976&partnerID=8YFLogxK

U2 - 10.3233/JAD-2012-120358

DO - 10.3233/JAD-2012-120358

M3 - Article

C2 - 22890094

AN - SCOPUS:84872311976

VL - 32

SP - 919

EP - 926

JO - Journal of Alzheimer's Disease

JF - Journal of Alzheimer's Disease

SN - 1387-2877

IS - 4

ER -